Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy

References

• Al-Abd AM, Aljehani ZK, Gazzaz RW, et al. (2015). Pharmacokinetic strategies to improve drug penetration and entrapment within solid tumors. J Controll Release 219:269–77.
   PubMed Web of Science ®Google Scholar
• Al-Jamal KT, Bai J, Wang JT-W, et al. (2016). Magnetic drug targeting: preclinical in vivo studies, mathematical modeling, and extrapolation to humans. Nano Lett 16:5652–60.
   PubMed Web of Science ®Google Scholar
• Ansaloni L, Coccolini F, Morosi L, et al. (2015). Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer. Br J Cancer 112:306–12.
   PubMed Web of Science ®Google Scholar
• Au JL-S, Guo P, Gao Y, et al. (2014). Multiscale tumor spatiokinetic model for intraperitoneal therapy. AAPS J 16:424–39.
   PubMed Web of Science ®Google Scholar
• Au JL-S, Yeung BZ, Wientjes MG, et al. (2016). Delivery of cancer therapeutics to extracellular and intracellular targets: determinants, barriers, challenges and opportunities. Adv Drug Deliv Rev 97:280–301.
   PubMed Web of Science ®Google Scholar
• Barakat RR, Sabbatini P, Bhaskaran D, et al. (2002). Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol 20:694–8.
   PubMed Web of Science ®Google Scholar
• Baxter LT, Jain RK. (1989). Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc Res 37:77–104.
   PubMed Web of Science ®Google Scholar
• Baxter LT, Jain RK. (1990). Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics. Microvasc Res 40:246–63.
   PubMed Web of Science ®Google Scholar
• Baxter LT, Jain RK. (1991). Transport of fluid and macromolecules in tumors: III. Role of binding and metabolism. Microvasc Res 41:5–23.
   PubMed Web of Science ®Google Scholar
• Boucher Y, Baxter LT, Jain RK. (1990). Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50:4478–84.
   PubMed Web of Science ®Google Scholar
• Carlier C, Mathys A, De Jaeghere E, et al. (2017). Tumor tissue transport after intraperitoneal anticancer drug delivery. Int J Hyperthermia 33:534–42.
   PubMed Web of Science ®Google Scholar
• Ceelen WP, Flessner MF. (2010). Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol 7:108–15.
   PubMed Web of Science ®Google Scholar
• Ceelen WP, Levine E. (2015). Intraperitoneal cancer therapy: principles and practice. Boca Raton, FL: CRC Press.
   Google Scholar
• Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. (2011). Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng 2:281–98.
   PubMed Web of Science ®Google Scholar
• Choi J, Credit K, Henderson K, et al. (2006). Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration. Clin Cancer Res 12:1906–12.
   PubMed Web of Science ®Google Scholar
• COMSOL. (2008). Multiphysics 3.5, C., Model library.
   Google Scholar
• COMSOL. (2012). Multiphysics, C., Comsol multiphysics user guide (version 4.3 a). COMSOL, AB, 39-40.
   Google Scholar
• Dakwar GR, Shariati M, Willaert W, et al. (2017). Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis—mission possible?. Adv Drug Deliv Rev 108:13–24.
   PubMed Web of Science ®Google Scholar
• David AE, Cole AJ, Chertok B, et al. (2011). A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. J Control Release 152:67–75.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Secomb TW. (2017). Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer 17:738–50.
   PubMed Web of Science ®Google Scholar
• Diver DA, Lubbe AS. (2007). Control to concentrate drug-coated magnetic particles to deep-tissue tumors for targeted cancer chemotherapy. Decision and Control, 2007 46th IEEE Conference on. IEEE, pp. 3901–3906.
   Google Scholar
• Flessner MF, Choi J, Credit K, et al. (2005). Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors. Clin Cancer Res 11:3117–25.
   PubMed Web of Science ®Google Scholar
• Fournier RL. (2012). Basic transport phenomena in biomedical engineering. Boca Raton, FL: CRC press.
   Google Scholar
• Frantz C, Stewart KM, Weaver VM. (2010). The extracellular matrix at a glance. J Cell Sci 123:4195–200.
   PubMed Web of Science ®Google Scholar
• Ganguly R, Gaind AP, Sen S, Puri IK. (2005). Analyzing ferrofluid transport for magnetic drug targeting. J Magn Magn Mater 289:331–4.
   Web of Science ®Google Scholar
• Gao Y, Li M, Chen B, et al. (2013). Predictive models of diffusive nanoparticle transport in 3-dimensional tumor cell spheroids. Aaps J 15:816–31.
   PubMed Web of Science ®Google Scholar
• Goodwin S, Peterson C, Hoh C, Bittner C. (1999). Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. J Magn Magn Mater 194:132–9.
   Web of Science ®Google Scholar
• Gremonprez F, Descamps B, Izmer A, et al. (2015). Pretreatment with VEGF (R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model. Oncotarget 6:29889.
   PubMed Web of Science ®Google Scholar
• Haus HA, Melcher JR. (1989). Electromagnetic fields and energy. Englewood Cliffs, NJ: Prentice Hall.
   Google Scholar
• Heldin C-H, Rubin K, Pietras K, Östman A. (2004). High interstitial fluid pressure—an obstacle in cancer therapy. Nat Rev Cancer 4:806–13.
   PubMed Web of Science ®Google Scholar
• Jain RK. (2013). Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol 31:2205–18.
   PubMed Web of Science ®Google Scholar
• Jain RK, Martin JD, Stylianopoulos T. (2014). The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng 16:321–46.
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. (2010). Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7:653–64.
   PubMed Web of Science ®Google Scholar
• Khawar IA, Kim JH, Kuh H-J. (2015). Improving drug delivery to solid tumors: priming the tumor microenvironment. J Control Release 201:78–89.
   PubMed Web of Science ®Google Scholar
• Kim D, Armenante PM, Durán WN. (1990). Mathematical modeling of mass transfer in microvascular wall and interstitial space. Microvascul Res 40:358–78.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Ramaswamy B, Horton E, et al. (2015). Quantifying the motion of magnetic particles in excised tissue: effect of particle properties and applied magnetic field. J Magn Magn Mater 393:243–52.
   PubMed Web of Science ®Google Scholar
• Lambert LA. (2015). Looking up: recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin 65:283–98.
   Web of Science ®Google Scholar
• Levick J. (1987). Flow through interstitium and other fibrous matrices. Exp Physiol 72:409–37.
   Web of Science ®Google Scholar
• Lieleg O, Ribbeck K. (2011). Biological hydrogels as selective diffusion barriers. Trends Cell Biol 21:543–51.
   PubMed Web of Science ®Google Scholar
• Liu L, Brown S, Ewing J, Schlesinger M. (2011). Phenomenological model of interstitial fluid pressure in a solid tumor. Phys Rev E 84:021919.
   Web of Science ®Google Scholar
• Lübbe AS, Bergemann C, Riess H, et al. (1996). Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56:4686–93.
   PubMed Web of Science ®Google Scholar
• Ma P, Luo Q, Chen J, et al. (2012). Intraperitoneal injection of magnetic Fe3O4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int J Nanomed 7:4809.
   PubMed Web of Science ®Google Scholar
• Miao L, Lin CM, Huang L. (2015). Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. J Control Release 219:192–204.
   PubMed Web of Science ®Google Scholar
• Minchinton AI, Tannock IF. (2006). Drug penetration in solid tumours. Nat Rev Cancer 6:583–92.
   PubMed Web of Science ®Google Scholar
• Mirahmadi N, Babaei M, Vali A, Dadashzadeh S. (2010). Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice. Int J Pharm 383:7–13.
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Jain RK, Langer R. (2017). Engineering and physical sciences in oncology: challenges and opportunities. Nat Rev Cancer 17:659–75.
   PubMed Web of Science ®Google Scholar
• Modarres HP, Janmaleki M, Novin M, et al. (2018). In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain. J Control Release 273:108–30.
   PubMed Web of Science ®Google Scholar
• Montori G, Coccolini F, Ceresoli M, et al. (2014). The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art. Int J Surg Oncol 2014. http://dx.doi.org/10.1155/2014/912418
   PubMedGoogle Scholar
• Nacev A, Beni C, Bruno O, Shapiro B. (2010). Magnetic nanoparticle transport within flowing blood and into surrounding tissue. Nanomedicine 5:1459–66.
   PubMed Web of Science ®Google Scholar
• Nacev A, Beni C, Bruno O, Shapiro B. (2011a). The behaviors of ferromagnetic nano-particles in and around blood vessels under applied magnetic fields. J Magn Magn Mater 323:651–68.
   PubMed Web of Science ®Google Scholar
• Nacev A, Kim SH, Rodriguez-Canales J, et al. (2011b). A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens. Int J Nanomed 6:2907.
   PubMed Web of Science ®Google Scholar
• Nacev A, Komaee A, Sarwar A, et al. (2012). Towards control of magnetic fluids in patients: directing therapeutic nanoparticles to disease locations. IEEE Control Syst 32:32–74.
   Web of Science ®Google Scholar
• Nacev AN. (2013). Magnetic drug targeting: developing the basics. College Park: University of Maryland.
   Google Scholar
• Nakai Y, Isayama H, Ijichi H, et al. (2013). A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2. Investig New Drugs 31:1294–9.
   PubMed Web of Science ®Google Scholar
• Ne’mati SMA, Ghassemi M, Shahidian A. (2017). Numerical investigation of drug delivery to cancerous solid tumors by magnetic nanoparticles using external magnet. Transp Porous Med 119:461–80.
   Web of Science ®Google Scholar
• Orlanski I. (1976). A simple boundary condition for unbounded hyperbolic flows. J Comput Phys 21:251–69.
   Web of Science ®Google Scholar
• Padera T, Stoll B, Tooredman J, et al. (2004). Cancer cells compress intratumour vessels: pressure from proliferating cells impedes transport of therapeutic drugs into tumors. Nature 247:695.
   Web of Science ®Google Scholar
• Patel R. (2012). Effective viscosity of magnetic nanofluids through capillaries. Phys Rev E 85:026316.
   Web of Science ®Google Scholar
• Pham BT, Colvin EK, Pham NT, et al. (2018). Biodistribution and clearance of stable superparamagnetic maghemite iron oxide nanoparticles in mice following intraperitoneal administration. Int J Mol Sci 19:205.
   Web of Science ®Google Scholar
• Prodan AM, Iconaru SL, Ciobanu CS, et al. (2013). Iron oxide magnetic nanoparticles: characterization and toxicity evaluation by in vitro and in vivo assays. J Nanomater 2013:5.
   Web of Science ®Google Scholar
• Puri IK, Ganguly R. (2014). Particle transport in therapeutic magnetic fields. Annu Rev Fluid Mech 46:407–40.
   Web of Science ®Google Scholar
• Reddy LH, Arias JL, Nicolas J, Couvreur P. (2012). Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 112:5818–78.
   PubMed Web of Science ®Google Scholar
• Sarwar A, Nemirovski A, Shapiro B. (2012). Optimal Halbach permanent magnet designs for maximally pulling and pushing nanoparticles. J Magn Magn Mater 324:742–54.
   PubMed Web of Science ®Google Scholar
• Sefidgar M, Soltani M, Raahemifar K, et al. (2014). Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors. J Biol Eng 8:12.
   PubMed Web of Science ®Google Scholar
• Shah DK, Shin BS, Veith J, et al. (2009). Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy. J Pharmacol Exp Ther 329:580–91.
   PubMed Web of Science ®Google Scholar
• Shapiro B. (2009). Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body. J Magn Magn Mater 321:1594–9.
   PubMed Web of Science ®Google Scholar
• Shaw S, Murthy P, Sibanda P. (2013). Magnetic drug targeting in a permeable microvessel. Microvasc Res 85:77–85.
   PubMed Web of Science ®Google Scholar
• Sloothaak D, Mirck B, Punt C, et al. (2014). Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review. Br J Cancer 111:1112–21.
   PubMed Web of Science ®Google Scholar
• Soleimani S, Shamsi M, Ghazani MA, et al. (2018). Translational models of tumor angiogenesis: a nexus of in silico and in vitro models. Biotechnol Adv 18:30013–2.
   Google Scholar
• Soltani M, Chen P. (2011). Numerical modeling of fluid flow in solid tumors. PloS One 6:e20344.
   PubMed Web of Science ®Google Scholar
• Steuperaert M, Falvo D’Urso Labate G, Debbaut C, et al. (2017). Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule. Drug Deliv 24:491–501.
   PubMed Web of Science ®Google Scholar
• Stewart JH, Shen P, Russell GB, et al. (2006). Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 13:624–34.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Jain RK. (2013). Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci 110:18632–7.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Soteriou K, Fukumura D, Jain RK. (2013). Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model. Ann Biomed Eng 41:68–77.
   PubMed Web of Science ®Google Scholar
• Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. (2016). Extracellular matrix structure. Adv Drug Deliv Rev 97:4–27.
   PubMed Web of Science ®Google Scholar
• Valente KP, Khetani S, Kolahchi AR, et al. (2017). Microfluidic technologies for anticancer drug studies. Drug Discov Today 22:1654–70.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang M. (2010). Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 62:284–304.
   PubMed Web of Science ®Google Scholar
• Wademan M, Ha J, Singh H, et al. (2012). Current indications, techniques and results of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for intra-abdominal malignancies. Surg Curr Res 2:125.
   Google Scholar
• Williamson SK, Johnson GA, Maulhardt HA, et al. (2015). A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies. Cancer Chemother Pharmacol 75:1075–1087.
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. (2001). Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27:365–374.
   PubMed Web of Science ®Google Scholar
• Witten J, Ribbeck K. (2017). The particle in the spider's web: transport through biological hydrogels. Nanoscale 9:8080–8095.
   PubMed Web of Science ®Google Scholar
• Wright AA, Cronin A, Milne DE, et al. (2015). Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer. J Clin Oncol 33:2841–2847.
   PubMed Web of Science ®Google Scholar
• Wu M, Frieboes HB, Chaplain MA, et al. (2014). The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems. J Theor Biol 355:194–207.
   PubMed Web of Science ®Google Scholar
• Zhang YS, Aleman J, Shin SR, et al. (2017). Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc Natl Acad Sci 114:2293–2302.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Carlsson O, Rippe B. (1998). Clearance of tracer albumin from peritoneal cavity to plasma at low intraperitoneal volumes and hydrostatic pressures. Perit Dial Int 18:497–504.
   PubMed Web of Science ®Google Scholar